{"id":"W4416293333","doi":"10.1016/j.ejim.2025.106584","title":"Mepolizumab improves health-related quality of life in patients with hypereosinophilic syndrome","year":2025,"lang":"en","type":"article","venue":"European Journal of Internal Medicine","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Mepolizumab; Hypereosinophilic syndrome; Eosinophil; Eosinophilia; Monoclonal; Quality of life (healthcare); Monoclonal antibody; Eosinophilic","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001790685,0.0002203168,0.001334481,0.0006836378,0.00002946328,0.000006648454,0.0002880184,0.00003419877,0.0001144228],"category_scores_gemma":[0.0009715274,0.000137084,0.0001320309,0.000451535,0.0002786204,0.00009808013,0.00005696281,0.0005566279,0.00000482211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001076648,"about_ca_system_score_gemma":0.0002678593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000300622,"about_ca_topic_score_gemma":0.00001179662,"domain_scores_codex":[0.9960788,0.0004744648,0.002378247,0.0001957731,0.0006143324,0.0002583221],"domain_scores_gemma":[0.9976392,0.0001292779,0.001267442,0.000289129,0.0003996768,0.0002752229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006409975,0.001513717,0.9561983,0.0009556581,0.000954925,0.0009312974,0.001739286,0.000008858193,0.0009823625,0.0004971114,0.002973712,0.0268348],"study_design_scores_gemma":[0.01590094,0.008124941,0.9689772,0.005641574,0.00006989251,0.0003232032,0.0004116656,0.000005180839,0.0000179074,0.0001014645,0.0003282615,0.00009777856],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808221,0.003198055,0.00007844136,0.006163517,0.0004258208,0.0002393553,0.000003207402,0.00001084252,0.009058645],"genre_scores_gemma":[0.9974301,0.00009284816,0.0001880862,0.001626181,0.00005173849,5.150716e-7,0.000004095332,0.00002763184,0.0005787477],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02673703,"threshold_uncertainty_score":0.5590124,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01614377238689291,"score_gpt":0.2757440658033898,"score_spread":0.2596002934164969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}